Navigation Links
Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
Date:5/6/2013

ties and Exchange Commission. Because these statements reflect current expectations concerning future events, actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors. These factors include, but are not limited to, the ability of Novartis and our other partners to continue to fund and successfully progress research and development efforts with respect to drugs we have licensed to them; risks associated with dependence on collaborators for the clinical development and commercialization of out-licensed drug candidates; the ability to effectively and timely conduct clinical trials in light of increasing costs and difficulties in locating appropriate trial sites and in enrolling patients who meet the criteria for certain clinical trials; and risks associated with dependence on third-party service providers to successfully conduct clinical trials within and outside the United States. Array is providing this information as of May 6, 2013 and undertakes no duty to update any forward-looking statements to reflect the occurrence of events or circumstances after the date of such statements or of anticipated or unanticipated events that alter any assumptions underlying such statements.

CONTACT:

Tricia Haugeto


(303) 386-1193


thaugeto@arraybiopharma.com


'/>"/>
SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
3. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
4. Array BioPharma Announces Proposed Public Offering Of Common Stock
5. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
6. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
7. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
10. Array BioPharma To Present At The Cowen Annual Health Care Conference
11. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Investor-Edge has initiated coverage on the following equities: ... Company (NYSE: LLY ), Nektar Therapeutics (NASDAQ: ... Novartis AG (NYSE: NVS ). Free research on ... . On Friday, December 12, 2014, the NASDAQ Composite ... lost 1.79%, to finish the day at 17,280.83, and the ...
(Date:12/15/2014)... , Dec. 15, 2014  Stephen Squires, CEO and ... Quantum Materials Corp (OTCQB:QTMM), will be speaking at ... Materials (RCQM) on December 16th, 2014. The RCQM launch ... nanomaterials in attracting top faculty and students and by ... on research. "We have a long ...
(Date:12/15/2014)...  The Government of Ghana has endorsed ... (GBF) and Terumo BCT to respond to the emerging Ebola crisis ... long-term health system capacity to the citizens of Ghana ... Ebola Readiness and Resilience Initiative (GERRI) is a multi-agency effort designed ... the possible arrival of the Ebola epidemic , Provide new ...
Breaking Medicine Technology:Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6
... , , , ... The rating agency Moody,s changed the outlook for ... , Moody,s gave as a ... the group,s business model. , , , ...
... INDIANAPOLIS , April 22 Today, WellPoint, Inc. (NYSE: ... article published this morning. , , ... Today,s Reuters story alleging that WellPoint employs a ... inaccurate and grossly misleading . The story incorrectly reports that WellPoint singles out ...
Cached Medicine Technology:Moody's Raised Outlook for Gerresheimer 2WellPoint's Reuters Response 2WellPoint's Reuters Response 3WellPoint's Reuters Response 4
(Date:12/17/2014)... HealthDay Reporter TUESDAY, Dec. 16, 2014 (HealthDay ... new study reveals that states that routinely perform randomized traffic ... their roads. The finding suggests that states that enforce ... inebriated revelers from getting behind the wheel in the first ... drinking and driving," said study lead author James Fell, a ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... work commitment is a big reason why, new research suggests. ... Mathias Basner, an assistant professor of sleep and chronobiology in ... A time-use survey of nearly 125,000 Americans, ages 15 ... exchanged for sleep. Short sleepers -- those who slept six ...
(Date:12/15/2014)... Cancer researchers have just published an ... of deadly malignant pleural mesothelioma. Surviving Mesothelioma has just ... Click here to read it now. , ... Center, and New York’s Langone Medical Center performed complete ... in an effort to pinpoint the genes that ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), ... a new study providing evidence on the impact of ... children. , Sufficient enough evidence already exists showing a ... juice drinks, with the onset of tooth decay. One ... listed as 100% fruit juice, meaning it is completely ...
(Date:12/15/2014)... a leading mobile app development company , custom ... which allows users to keep track of wines they ... right wine. At the center of WineMatch is ... wine information. All this information is assembled to help ... are close counterparts to one another are called Matches. ...
Breaking Medicine News(10 mins):Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2
... "The Senate compromise version of H.R. 1, the American ... to the thousands of state and local government public ... - including those who work in laboratories," said Scott ... Laboratories. "Unfortunately, the Senate has decided that these workers ...
... WASHINGTON, Feb. 10 More than 170 public health ... them to maintain the House-passed level of funding for ... Recovery Act of 2009. The final U.S. Senate version ... funding in the House stimulus could directly save or ...
... www.NBTY.com ), a leading global manufacturer and marketer of nutritional supplements, today announced the following preliminary unaudited net sales results for the month of ... NET SALES, ... FOR THE MONTH OF JANUARY, ... ($In Millions), ...
... and EPS Guidance , BETHESDA, Md., Feb. 10 Hanger ... sales of $185.5 million for the quarter ended December 31, ... million in the prior year,s comparable quarter. Pre-tax income ... fourth quarter 2008 from $10.0 million in the same quarter ...
... growing core businessesCHICAGO, Feb. 10 Allscripts-Misys Healthcare Solutions, ... agreement in principle, subject to negotiation of and entry ... business. Closing of the transaction is expected to be ... be given that a definitive agreement for the sale ...
... Feb. 10 During scheduled visits to Members of ... Homecare and its members will urge Congress and the ... the Medicare Anti-Fraud Legislative Plan. Developed by the ... tough, effective measures to stop waste, fraud and abuse ...
Cached Medicine News:Health News:Laid Off Public Health Workers Excluded From Senate Stimulus, Governmental Health Laboratories Slammed by Recession 2Health News:Over 170 Groups Urge Bill Conferees to Include 'Double Duty' Public Health Funds in Stimulus for Jobs and Health Care Savings 2Health News:Over 170 Groups Urge Bill Conferees to Include 'Double Duty' Public Health Funds in Stimulus for Jobs and Health Care Savings 3Health News:Over 170 Groups Urge Bill Conferees to Include 'Double Duty' Public Health Funds in Stimulus for Jobs and Health Care Savings 4Health News:Over 170 Groups Urge Bill Conferees to Include 'Double Duty' Public Health Funds in Stimulus for Jobs and Health Care Savings 5Health News:Over 170 Groups Urge Bill Conferees to Include 'Double Duty' Public Health Funds in Stimulus for Jobs and Health Care Savings 6Health News:Over 170 Groups Urge Bill Conferees to Include 'Double Duty' Public Health Funds in Stimulus for Jobs and Health Care Savings 7Health News:NBTY Announces Preliminary Unaudited Net Sales Results for January 2009 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results for January 2009 3Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 2Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 3Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 4Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 5Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 6Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 7Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 8Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 9Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 10Health News:Allscripts Announces Agreement in Principle to Sell Its Medication Services Business 2Health News:Allscripts Announces Agreement in Principle to Sell Its Medication Services Business 3Health News:American Association for Homecare Proposes to Congress a Medicare Anti-Fraud Action Plan that Includes Increased Penalties, Site Inspection, and Tough Standards 2Health News:American Association for Homecare Proposes to Congress a Medicare Anti-Fraud Action Plan that Includes Increased Penalties, Site Inspection, and Tough Standards 3Health News:American Association for Homecare Proposes to Congress a Medicare Anti-Fraud Action Plan that Includes Increased Penalties, Site Inspection, and Tough Standards 4
Curved shafts and tips with tying surfaces. Wide serrated handle with dull finish. Overall length 4.3 inches....
Curved shafts and tips with 7 mm tying platform. Serrated handle with polished finish. Overall length 4 inches....
Straight shafts with 5 mm tying platform. Wide handle with dull finish. Overall length 4.3 inches....
Straight shafts with 7 mm tying platform. Flat serrated handle with dull titanium finish. Overall length 4.5 inches....
Medicine Products: